The successful combination of traditional treatment and Ovosan stabilized Ms. Jana’s health condition. Ovosan contributed to the improvement of health.
Mrs. Jana from Bělá pod Bezdězem was diagnosed with vulvar cancer in June 2011. She underwent surgery, which was successful, and the tumor was removed with negative margins, so no further treatment was necessary.
However, in May 2018, Ms. Jana was hospitalized due to suspected cholecystitis. However, a CT scan revealed an expansion in the small pelvis, which led to the suspicion of ovarian cancer. Her level of the tumor marker CA125 was over 1000 ( note: the normal value is ≤ 35 ). While waiting for the planned surgery, Mrs. Jana was recommended to take Ovosan at a dose of 7-7-7 capsules per day as a treatment support.
Surgery and subsequent treatment with radiotherapy and Ovosan
In June 2018, her son mentioned that she had a urinary tract infection, so she was put on antibiotics and a consultation with a gynecologist was arranged for a planned surgery. In August 2018, just three months after the diagnosis, she underwent surgery, during which she was already diagnosed with adenocarcinoma with spread to the lymph nodes.
This was followed by radiotherapy, which Ms. Jana managed without major complications, and continued to take Ovosan at a dose of 6-6-6 capsules per day. In December 2018, a follow-up CT scan of the abdomen showed significant regression of the left adnexal expansion and the patient felt well.
In 2019, Ms. Jana continued to take Ovosan and her condition stabilized. She felt good and continued to take Ovosan, this time at a dose of 4-4-4. In March 2020, an ultrasound showed a stationary finding in the small pelvis and her health was good. She continued to take Ovosan as a prevention against COVID-19.
In September 2020, a follow-up ultrasound showed stable findings again and the patient was without complications. In February 2021, her son reported that her condition was stabilized and that COVID-19 had eluded her.
In March 2022, her son reported that she had been experiencing stomach problems due to arthritis and medrol treatment, but her condition remained stable. She temporarily discontinued Ovosan and is now back on it at a dose of 3-3-3 capsules per day.
Current status: How is Ms. Jana doing now?
Ms. Jana’s story shows how important supportive care can play in the fight against cancer. Despite serious health complications and demanding surgeries, her condition stabilized thanks to a combination of traditional treatment and support with Ovosan. Ovosan not only contributed to improving her quality of life, but also helped her overcome oncological challenges and strengthen her immune system during the COVID-19 pandemic. Ms. Jana, as well as her son, are convinced of the benefits of Ovosan, although its higher price may be an obstacle for some patients.
According to Jana’s son, Ovosan helped not only in the fight against her oncological disease, but also as a prevention against COVID-19. “I believe that Ovosan helped me extend my life and increase its quality despite my disease. I definitely do not regret the money spent,” says Ms. Jana.